Software developed by Wellington technology company Mātakina has been chosen for use in a Dutch breast screening trial.
Mātakina has developed advanced image-processing software called Volpara that measures breast density and can be used with any existing breast imaging system.
Around a million women are screened every year in the Netherlands, and the DENSE trial, run by the Dutch Breast Screening Organizations and University Medical Center Utrecht (UMCU),will seek to determine the cost-effectiveness of biennial screening with mammography and MRI compared to mammography alone in women aged 50-75 and who have extremely dense breasts.
Volpara will be used to select a subset of the population for additional screening using breast MRI and their results will be compared to those who follow the usual mammography screening programme.
“Automated, objective density assessment was critical for this project, and Volpara, with its robust nature and clinical track-record is the perfect tool for the job," said Dr Carla van Gils from UMCU.
Volpara is in use across the US, South Korea and Malaysia and locally, the Auckland Breast Centre has been trialling the software for the last month, and will be fully adopting it later this month.